The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014, driven by the high demand for the biomarkers in the field of drug discovery.
Online PR News – 02-September-2009 – – Wilmington, Del.-The Global Biomarker Market report analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and also evaluates the major trends in the macro- and micro-markets with respect to different geographic regions.
Browse more than 111 market data tables and in-depth TOC on biomarker market.
Early buyers will receive 10% customization of reports.
The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014, driven by the high demand for the biomarkers in the field of drug discovery. The markets for biomarker tools and services are expected to grow at a CAGR of 18.5% and 22.2% respectively. The increasing use of biomarkers in clinical services is boosting the overall biomarker service market.
The high growth of biomarker market is boosted by the demand from the baby boomer generation in the U.S., and from Asia’s emerging IT industry. Biomarker applications are increasing in cancer diagnosis as novel tools are being developed to increase the discovery speed of cancer biomarkers. The use of proteomics in biomarker testing and identification has in turn boosted the services for the biomarkers. Market players are now focusing on new product and service development to enhance their commercial portfolios. Strategic collaborations among companies are also increasing biomarker applications in the field of diagnosis and drug discovery.
SCOPE AND FORMAT
The report analyzes the global biomarker market into the following segments:
* Tools Market (pregenomic biomarkers and technologies, postgenomic biomarkers and technologies, imaging biomarkers, and others)
* Services Market (pre- and post-clinical biomarker services, sample preparation, mirna analysis, and others)
* Application Market (diagnosis, and drug development and discovery)
The market data consists of aggregate sales figures of all biomarker submarkets. It analyzes the market aspects of new biomarker technologies and product launches; sourcing key market developments from the top companies that it profiles. The report also analyzes the documented claims and the biomarker technology patents approved over the last five years to provide an in-depth understanding of biomarker tools and services.
Analyst Briefings on 11th Sep 2009
The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global Biomarker Market to be held on 11th September, 2009. The briefing on the Global Biomarker market (2009-2014) will benefit the Active pharmaceutical ingredients (APIs) manufacturers, contract research organizations, drug manufacturers, medical/pharma associations, research labs, healthcare service providers, regulatory authorities, and technology providers.
To register your participation, please click here
MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at www.marketsandmarkets.com.